Phentermine HCL 37.5mg (Calvin Scott) – Light Sensitivity Packaging (2020)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Phentermine HCL Blue Speckled tablets, 37.5 mg, packaged in a) 14-count bags (NDC 10702-0025-10) and b) 28-count bags (NDC 10702-0025-10), Rx Only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech., Inc Newtown, PA 18940.
Brand
Calvin Scott & Company, Inc.
Lot Codes / Batch Numbers
Lot #: a) 19271, Exp. Date 10/20 b) 19206, 19209B, Exp. Date 08/20, 19229, Exp. Date 10/20, 19255, Exp. Date 09/20, 19271, Exp. Date 08/20, 19301, Exp. Date 10/20, 19327, Exp. Date 11/20, 19336, Exp. 12/20, 20012, Exp. Date 1/21, 20045, Exp. Date 2/21.
Products Sold
Lot #: a) 19271, Exp. Date 10/20 b) 19206, 19209B, Exp. Date 08/20; 19229, Exp. Date 10/20; 19255, Exp. Date 09/20; 19271, Exp. Date 08/20; 19301, Exp. Date 10/20; 19327, Exp. Date 11/20; 19336, Exp. 12/20; 20012, Exp. Date 1/21; 20045, Exp. Date 2/21.
Calvin Scott & Company, Inc. is recalling Phentermine HCL Blue Speckled tablets, 37.5 mg, packaged in a) 14-count bags (NDC 10702-0025-10) a due to CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026